Fukushima Y, Oka Y, Saitoh T, Katagiri H, Asano T, Matsuhashi N, Takata K, van Breda E, Yazaki Y, Sugano K
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
Biochem J. 1995 Sep 1;310 ( Pt 2)(Pt 2):553-8. doi: 10.1042/bj3100553.
G-protein-coupled receptors generally share a similar structure containing seven membrane-spanning domains and extracellular site(s) for N-glycosylation. The histamine H2 receptor is a member of the family of G-protein-coupled receptors, and has three extracellular potential sites for N-glycosylation (Asn-4, Asn-162 and Asn-168). To date, however, no information has been presented regarding N-glycosylation of the H2 receptor. To investigate the presence, location and functional roles of N-glycosylation of the H2 receptor, site-directed mutagenesis was performed to eliminate the potential site(s) for N-glycosylation singly and collectively. The wild-type and mutated H2 receptors were expressed stably in Chinese hamster ovary (CHO) cells or transiently in COS7 cells. Immunoblotting of the wild-type and mutated H2 receptors with an antiserum directed against the C-terminus of the H2 receptor showed that mutation at Asn-162, but not at Asn-168, resulted in a substantial decrease in the molecular mass. A mutation at Asn-4 led to a further decrease in the molecular mass. Tunicamycin treatment of the transfected cells yielded a sharp band with a molecular mass identical to that of the mutant devoid of all three potential sites for N-glycosylation. These findings indicate that the H2 receptor is N-glycosylated, and that N-glycosylation takes place mainly at two sites, Asn-4 and Asn-162. Neither the affinity for tiotidine nor that for histamine was affected by the mutagenesis. Immunocytochemistry and tiotidine binding showed that the mutated receptors were exclusively distributed on the cell surface in a fashion similar to that of the wild-type. In addition, the glycosylation-defective receptor was capable of activating adenylate cyclase and elevating the intracellular Ca2+ concentration in response to histamine in stable CHO cell lines. Thus N-glycosylation of the H2 receptor is not required for cell surface localization, ligand binding or functional coupling to G-protein(s).
G蛋白偶联受体通常具有相似的结构,包含七个跨膜结构域和用于N-糖基化的细胞外位点。组胺H2受体是G蛋白偶联受体家族的成员,有三个潜在的N-糖基化细胞外位点(天冬酰胺-4、天冬酰胺-162和天冬酰胺-168)。然而,迄今为止,尚未有关于H2受体N-糖基化的信息。为了研究H2受体N-糖基化的存在、位置和功能作用,进行了定点诱变,以单独或共同消除潜在的N-糖基化位点。野生型和突变型H2受体在中国仓鼠卵巢(CHO)细胞中稳定表达,或在COS7细胞中瞬时表达。用针对H2受体C末端的抗血清对野生型和突变型H2受体进行免疫印迹分析表明,天冬酰胺-162位点的突变而非天冬酰胺-168位点的突变导致分子量显著降低。天冬酰胺-4位点的突变导致分子量进一步降低。用衣霉素处理转染细胞产生了一条分子量与缺乏所有三个潜在N-糖基化位点的突变体相同的清晰条带。这些发现表明H2受体发生了N-糖基化,且N-糖基化主要发生在两个位点,即天冬酰胺-4和天冬酰胺-162。诱变既不影响对替丁的亲和力,也不影响对组胺的亲和力。免疫细胞化学和替丁结合表明,突变受体以与野生型相似的方式仅分布在细胞表面。此外,糖基化缺陷型受体在稳定的CHO细胞系中能够响应组胺激活腺苷酸环化酶并提高细胞内Ca2+浓度。因此,H2受体的N-糖基化对于细胞表面定位、配体结合或与G蛋白的功能偶联并非必需。